New Diet Pill Approved by Fda

US FDA approves AstraZeneca's drug for breast cancer

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday.

Business Insider · 3h

Amgen's Lumakras+Vectibix Combo Gets FDA Approval For Metastatic Colorectal Cancer Treatment

Friday announced that the U.S. Food and Drug Administration has approved its Lumakras plus Vectibix combination

Investing.com on MSN · 4h

FDA approves new colorectal cancer treatment

THOUSAND OAKS, Calif. - Amgen (NASDAQ:AMGN), a prominent biotechnology company with a market capitalization of $144.8 billion, has received FDA approval for LUMAKRAS® (sotorasib) in combination with Vectibix® (panitumumab) to treat adult patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC).

Reuters on MSN · 19h

US FDA approves Amgen's colorectal cancer therapy

The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients with a specific gene mutation. Amgen's Lumakras in combination with Vectibix was approved to treat adult patients whose cancer has spread to other parts of the body despite receiving chemotherapy,

KRLD Radio Dallas on MSN1h

Nicotine pouches get FDA approval, with some calling them Gen Z's favorite weight loss hack

Little pouches of nicotine sold by the brand ZYN were given the green light for marketing this week through the U.S. Food and ...

Websites selling compounded weight-loss drugs fail to inform patients of risks, research shows

Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...

Meet ‘Super’ Ozempic: Higher Dose Semaglutide Leads to Even Greater Weight Loss In Major Trial

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

4don MSN

Billed as nonaddictive, new pain pill could soon win FDA approval

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

10don MSN

Ozempic 3.0? This drug causes the greatest weight loss — by far

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

NBC New York4d

Eli Lilly CEO expects new weight loss pill to be approved next year

Eli Lilly expects its experimental weight loss pill, orforglipron, to be approved as soon as early next year, CEO David Ricks told Bloomberg. Eli Lilly and Novo Nordisk, which dominate the ...

Ibj.com7d

Lilly sees new weight-loss pill approval in early 2026, CEO says

Indianapolis-based Eli Lilly and Co. is projecting approval of its experimental weight-loss pill as soon as early 2026, CEO Dave Ricks said, one of several in a new generation of the popular ...

2hon MSN

US FDA Approves Omvoh For Severe Crohn’s Disease Relief: All You Need To Know

The FDA has approved Omvoh (mirikizumab-mrkz) for treating moderately to severely active Crohn’s disease in adults. Clinical ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics